We prospectively investigated dietary flavonoid intake and esophageal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. The study included 477,312 adult subjects from 10 European countries. At baseline, country-specific validated dietary questionnaires were used. During a mean follow-up of 11 years (1992)(1993)(1994)(1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010), there were 341 incident esophageal cancer cases, of which 142 were esophageal adenocarcinoma (EAC), 176 were esophageal squamous cell carcinoma (ESCC), and 23 were other types of esophageal cancer. In crude models, a doubling in total dietary flavonoid intake was inversely associated with esophageal cancer risk (hazard ratio (HR) (log 2 ) = 0.87, 95% confidence interval (CI): 0.78, 0.98) but not in multivariable models (HR (log 2 ) = 0.97, 95% CI: 0.86, 1.10). After covariate adjustment, no statistically significant association was found between any flavonoid subclass and esophageal cancer, EAC, or ESCC. However, among current smokers, flavonols were statistically significantly associated with a reduced esophageal cancer risk (HR (log 2 ) = 0.72, 95% CI: 0.56, 0.94), whereas total flavonoids, flavanols, and flavan-3-ol monomers tended to be inversely associated with esophageal cancer risk. No associations were found in either never or former smokers. These findings suggest that dietary flavonoid intake was not associated with overall esophageal cancer, EAC, or ESCC risk, although total flavonoids and some flavonoid subclasses, particularly flavonols, may reduce the esophageal cancer risk among current smokers. esophageal cancer; European Prospective Investigation into Cancer and Nutrition; flavonoids; intake Abbreviations: CI, confidence interval; EAC, esophageal adenocarcinoma; EPIC, European Prospective Investigation into Cancer and Nutrition; ESCC, esophageal squamous cell carcinoma; HR, hazard ratio.
has decreased, whereas EAC has doubled in the last decades and there are indications that it continues to increase at a rate of 5%-10% per year worldwide (1) .
ESCC develops as the result of a sequence of histopathological changes that typically involves esophagitis, atrophy, dysplasia, carcinoma in situ, and finally invasive cancer (2) . It is located predominantly in the middle and the upper third of the esophagus. There is strong evidence that smoking and alcohol abuse are the major risk factors for developing ESCC (3, 4) . Most EAC arises from glandular cells and is located in the lower third of the esophagus, and Barrett's esophagus (5, 6) , smoking, and obesity are established risk factors of EAC (3, 6, 7) . Diet may play an important role in the etiology of esophageal cancer risk. High-temperature beverages and red and processed meat may increase the risk of developing overall esophageal cancer (7) (8) (9) , whereas low raw fruit and vegetable consumption has been associated with an increased risk of both esophageal cancer sites (10, 11) . Factors that may protect against the development of esophageal cancer include foods containing dietary fiber, folate, pyridoxine, carotenoids, and vitamins E and C (7, 9, 12, 13) . However, the epidemiologic evidence for the riskreducing dietary factors is limited (2) .
Flavonoids are a complex group of polyphenolic compounds that occur in plant-based foods such as fruits, vegetables, tea, and red wine (14) . In nature, they are usually found as glycosides (15) . Flavonoids are divided into 6 different subclasses: anthocyanidins, flavanols, flavanones, flavonols, flavones, and isoflavones. It is well known that flavonoids have antioxidative, antiinflammatory, and anticarcinogenic effects in animals and in vitro studies (16, 17) , including the ability to inhibit cell proliferation and enhance apoptosis in vitro (18, 19) . However, epidemiologic studies on this topic are scarce, and results have been inconclusive concerning flavonoids and esophageal cancer. An Italian case-control study found a significant inverse association between flavanones and ESCC risk (20) , but a US-based case-control study did not find any statistically significant association of flavonoids with risk for either EAC or ESCC (21) . To our knowledge, there are no prospective studies evaluating the association between dietary flavonoid intakes and esophageal cancer risk.
Further, there is very limited information on studies examining ESCC and EAC separately. Therefore, the aim of this study is to investigate the association between dietary intakes of total and subclasses of flavonoids and esophageal cancer (ESCC and EAC) risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Our hypothesis was that a higher intake of flavonoids, particularly flavanols and flavonols (the most abundant and probably the most bioactive flavonoid subclasses), would decrease esophageal cancer risk.
MATERIALS AND METHODS

Subjects and study design
EPIC is a large European multicenter prospective cohort designed mainly to investigate the relation between diet and cancer. In total, 521,448 eligible subjects (70.6% women) were recruited from the general population and included in the EPIC study. Most subjects were recruited between 1992 and 1998. The subjects were aged mainly between 35 and 70 years and originated from 23 centers in 10 European countries. The countries participating in the EPIC study were Denmark, France, Germany, Greece, Italy, Norway, Spain, Sweden, the Netherlands, and the United Kingdom. More detailed information about the EPIC study is described elsewhere (22) . The majority of the participants were from the general population, with the exceptions of France (women who were health insurance members), Utrecht and Florence (women attending breast cancer screening), Oxford (mostly health-conscious volunteers including a large proportion of vegetarians), and some centers in Spain and Italy that were mostly blood donors. Written consent was obtained from all participants. The study protocol was approved by the ethical review board of the International Agency for Research on Cancer and from the local ethics committees in participating countries.
Dietary assessment and data collection
At baseline, validated dietary country-specific questionnaires were used for recording usual diet over the preceding 12 months (22, 23) . Most centers used self-administered food frequency questionnaires. In the remaining centers (Greece, Spain, and Ragusa (Italy)), a face-to-face dietary questionnaire was used to collect dietary information. In Malmö (Sweden), a method combining a short nonquantitative food frequency questionnaire with a 7-day dietary diary was used. Total energy, alcohol, and nutrient intakes were estimated by using the standardized EPIC Nutrient Database (24) . A separate lifestyle questionnaire gathered information on sociodemographic characteristics, lifetime smoking, physical activity, education, and medical history (22) . In most centers, weight and height were also measured at recruitment. The exceptions were the centers of Oxford (United Kingdom), France, and Norway, where self-reported anthropometric values at baseline were collected.
Identification and follow-up of esophageal cancer cases
According to a centralized database at the International Agency for Research on Cancer, the last complete follow-up ranged from 2005 to 2010, depending on the center. Esophageal cancer cases were identified from information obtained by population cancer registries, with the exceptions of France, Germany, Greece, and Naples (Italy), where a combination of different active follow-up methods was used. Esophageal cancer cases were coded as C15 following the International Classification of Diseases, Tenth Revision. Morphology information was used to classify the malignant tumors into EAC and ESCC (according to the 2nd edition of the International Classification of Diseases for Oncology). Participants were excluded from the analyses when they had an extreme energy intake and/or expenditure ( participant in the top or the bottom 1% of the distribution of the ratio of total energy intake to energy requirement) or when there was incomplete information on dietary intake and lifestyle (n = 15,868). Furthermore, 28,268 participants were excluded because they had a prevalent cancer at any site or when they were lost to follow-up. In this present study, 477,312 subjects were included. No information was obtained in EPIC on Barrett's esophagus.
Flavonoid intake
Our food composition database (25-28) on flavonoids was based on US Department of Agriculture databases (29) (30) (31) , Phenol-Explorer (32) , and the United Kingdom Food Standards Agency database (33) . Furthermore, the flavonoid food composition database was expanded by using retention factors according to cooking and preparation methods, calculating flavonoid content of recipes, estimating missing values based on similar foods (by botanical species and plant part), and using botanical data for logical zeros. The final database for flavonoid intake contained 1,877 food items, with 10% missing values on these food items (25) (26) (27) (28) . Flavonoid intake was expressed as aglycones (mg/day) and was calculated as total and as subclasses (anthocyanidins, flavanols, flavanones, flavonols, flavones, and isoflavones). Flavanols were also divided into flavan-3-ol monomers, proanthocyanidins and theaflavins.
Statistical analysis
Distribution of flavonoid intake was assessed by the mean (standard deviation) as well as by the median (5th percentile, 95th percentile), since the data were skewed to the right. The association between dietary flavonoids and the risk of developing esophageal cancer was assessed by estimating the hazard ratio and its 95% confidence interval in Cox regression models. Tests and graphs based on Schoenfeld residuals were used to assess the proportional hazards assumption (34) . Age was the primary time variable, and entry time was defined as age at enrollment and exit time as age at diagnosis (for cases) or censoring (for at-risk subjects). All models were stratified by center to control for differences in questionnaire design and follow-up procedures among centers, by sex and by age at baseline (1-year intervals). All models were also adjusted for the categorical variables smoking status and intensity (never, former quit <11 years, former quit 11-20 years, former quit >20 years, current <15 cigarettes/ day, current 15-25 cigarettes/day, current >25 cigarettes/ day, current occasional, and not specified); educational level (none, primary school, technical/professional school, secondary school, university or higher, and not specified); and physical activity (inactive, moderately inactive, moderately active, active, and not specified). The continuous variables, which were adjusted for in all models, were total energy (kcal/day), body mass index (weight (kg)/height (m) 2 ), baseline alcohol (g/day), and red and processed meat intake (g/day). Further adjustments were done for intakes of dietary fiber (g/day), vitamin C (mg/day), and carotenoids (µg/day). The primary exposures, total flavonoids and flavonoid subclasses (mg/day), were analyzed as sex-specific quartiles, except for theaflavins, which were assessed in tertiles because there was a large group of nonconsumers that resulted in an unbalanced division of theaflavins in quartiles. In addition, tests for linear trend were performed by assigning the median of each quartile as scores. The continuous flavonoid variables (mg/day) were log 2 transformed because they were not normally distributed. Interactions between sex, body mass index, smoking status, alcohol consumption (non-low consumers, moderate consumers, high consumers), and flavonoid intake in relation to esophageal cancer risk were evaluated by using a likelihood ratio test based on the models with and without an interaction term. In addition, we assessed models stratified by smoking status because a statistically significant interaction with smoking status (never, former, and current smokers) was observed. Similar models were defined to assess the risk of esophageal cancer by histological type (EAC and ESCC). The Wald test statistic was used to evaluate heterogeneity by cancer subtypes. Sensitivity analyses were performed by excluding esophageal cancer cases in the first 2 years of follow-up from the analysis. All P values presented are 2-tailed and were considered to be statistically significant when P < 0.05. All statistical analyses were conducted by using SAS, version 9.3, software (SAS Institute, Inc., Cary, North Carolina).
RESULTS
The final cohort included 477,312 participants (29.8% men) who were followed for a mean of 11.0 (standard deviation, 2.8) years with a total of 5,262,993 person-years a The mean (standard deviation) values for the participant baseline characteristic, age in years, were 51.2 (9.9), 50.9 (9.2), 51.1 (9.6), 51.1 (9.6), and 51.8 (11.2) for all, quartile 1, quartile 2, quartile 3, and quartile 4, respectively.
b Quartiles of total flavonoid intake (mg/day) were sex specific. 
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Am J Epidemiol. 2013;178(4):570-581 (Table 1) . During this follow-up period, 341 cases (61.9% men) of esophageal cancer were identified, of which 142 were EAC (80.3% men) and 176 were ESCC (47.2% men). Baseline characteristics and daily dietary intake according to sex-specific quartiles of total flavonoid intake are shown in Tables 2 and 3 , respectively. Age at recruitment and percentage of men were higher in the fourth quartile compared with the first. In addition, participants in the highest quartile had the lowest body mass index; consumed more fiber, vitamin C, carotenoids, and alcohol; and had a lower consumption of processed meat. Furthermore, subjects in this quartile tended to smoke less, to have a higher educational level, and to be more physically active. Table 4 shows the mean (standard deviation) and the median and the 5% and 95% percentiles of daily intake of total flavonoids and flavonoid subclasses by sex. Median total flavonoid intakes were 335.0 mg/day in men and 332.2 mg/day in women.
A statistically significant inverse association was found in the crude models between esophageal cancer risk and doubling of total flavonoid intake (hazard ratio (HR) (log 2 ) = 0.87, 95% confidence interval (CI): 0.78, 0.98), flavanols, theaflavins, and flavanones (Table 5) , although in multivariate models, no significant associations were found with overall esophageal cancer. There were no statistically significant associations between EAC and ESCC and total flavonoids or any flavonoid subclass. Moreover, there was no evidence of heterogeneity between histological types. No statistically significant interactions between total flavonoid intake and esophageal cancer risk in the multivariate models by sex (P interaction = 0.968), body mass index (P interaction = 0.683), and baseline alcohol intake (P interaction = 0.247) were observed (data not shown).
Because a statistically significant interaction between smoking status (never, former, and current smoker) and total flavonoid intake in relation to esophageal cancer risk was Abbreviation: SD standard deviation. a Quartiles of total flavonoid intake (mg/day) were sex specific. observed (P interaction = 0.002), we stratified the statistical models by smoking status (Table 6 ). There were significant inverse associations between esophageal cancer risk and total flavonoids (HR (log 2 ) = 0.84, 95% CI: 0.71, 0.99) and some of the flavonoid subclasses (flavanols, flavan-3-ol monomers, and flavonols) in current smokers. No association was found between esophageal cancer risk and any flavonoid subclass in either never or former smokers, except for flavanones in former smokers. In current smokers after further adjustments for fiber, vitamin C, and carotenoids, the associations between flavonols and risk of esophageal cancer remained significant (HR (log 2 ) = 0.72, 95% CI: 0.56, 0.94), but became nonsignificant for total flavonoids, flavanols, and flavan-3-ol monomers. Sensitivity analyses were performed for the hazard ratio models by excluding cases diagnosed during the first 2 years of follow-up, resulting in the exclusion of 53 esophageal cancer cases (19 EAC, 34 ESCC). The hazard ratios for the sensitivity analyses were nearly identical to the results based on the whole cohort (for total flavonoids, HR (log 2 ) = 1.01, 95% CI: 0.88, 1.16). In a stratified analysis by smoking status, the magnitude of associations remained about the same, but hazard ratios became statistically nonsignificant (for total flavonoids, HR (log 2 ) = 0.88, 95% CI: 0.75, 1.04) because of wider confidence intervals.
DISCUSSION
In the present study, no significant associations were found between dietary flavonoids and their subclasses and esophageal cancer risk; however, in current smokers, we observed statistically significant inverse associations between dietary intake of total flavonoids, some subclasses (i.e., flavanols, flavan-3-ol monomers, and flavonols), and overall esophageal cancer risk.
A nested case-control study in Shanghai found an inverse association between urinary epigallocatechin gallate, a flavan-3-ol monomer which is used as a biomarker of tea consumption, and risk of gastric cancer and esophageal cancer combined (35) . Similar results were summarized in a review of green tea intake and esophageal cancer risk after controlling for the temperature of tea (36) . In addition, De Stefani et al. (37) showed that flavonoids were inversely related to the risk of upper aerodigestive tract cancers (including esophageal cancer) in a Uruguayan case-control study. However, this study was performed in 1999, and food composition data on flavonoids were very limited compared with what is available today.
In the present study, no significant associations were observed between dietary intake of flavonoids and risk of both EAC and ESCC. In a US case-control study, Bobe et al. did not observe an association between any flavonoid subclass and both EAC and ESCC (21); however, in an Italian case-control study, Rossi et al. found an inverse association between flavanones and ESCC risk. This could partially be explained by the higher median of flavanone intake in the Italian study compared with our study (33.5 mg/day vs. 22 mg/day). Moreover, the Italian study did not adjust for fiber and/or vitamin C intake that may have removed part of the true underlying association and did not adjust for other compounds present in fruit, and citrus fruit accounts for 90% of flavanone intake (20) . In the stratified models by smoking status, we found a significant inverse association between total flavonoids and several flavonoid subclasses (flavanols, flavan-3-ol monomers, and flavonols) and esophageal cancer risk in current smokers, whereas no associations were observed in never smokers. In former smokers, a significant inverse association was found between flavanone intake and overall esophageal cancer in our study, whereas in the Italian study, a stronger inverse association in current smokers between flavanones and ESCC has been reported (20) . Tobacco smoking causes oxidative stress, and both oxidative stress and smoking tobacco are related to increased esophageal cancer risk (37) . A stronger effect of dietary flavonoids in current smokers has also been found in other cancer sites, such as gastric (38) and pancreatic cancer (39) , but the opposite was observed in colorectal cancer (40) . Thus, our data suggest that the possible protective mechanism of dietary flavonoids may be related to their antioxidant properties, which may not be attributed to the direct antioxidant action, but to the ability to modulate antioxidant enzymatic pathways (41, 42) . Indeed, the flavonol, quercetin, is able to reduce the production of reactive oxygen species via modulating several signaling pathways, such as IRE1/JNK, PI3K/Akt, and FOXO3A (43, 44) . Moreover, a recent experimental study has shown that 2 flavonoids, sylimarin and naringenin, may have a protective effect against nicotineinduced oxidative stress in rats (45) . However, after the additional adjustment for fiber and other antioxidants present in fruits and vegetables, such as vitamin C and carotenoids, the associations between flavonoids and esophageal cancer risk were attenuated or became nonsignificant. So, other compounds in fruit and vegetables could also partially explain these inverse associations (2) .
The Italian case-control study also reported a stronger inverse association between dietary flavanones and ESCC in high-alcohol consumers (>6 drinks/day) (20) . However, no evidence of statistical heterogeneity by alcohol consumption was found in our study. Apart from potential antioxidant properties, other in vitro and in vivo studies showed the anticarcinogenic effects (16) (17) (18) (19) of several flavonoids on esophageal cancer risk, particularly through an influence on signaling pathways. In addition, the bioavailability of flavonoids in humans can vary substantially and might be influenced by variation in the absorption and metabolism (45) . Therefore, the potential effects of flavonoids can be reduced or modified (46, 47) .
This study has several potential limitations. The major limitation of this study is the relatively small number of esophageal cancer cases, especially for EAC in women (n = 28). However, this is the first prospective cohort study, with a relatively large sample size, which investigated the relation between dietary flavonoid intake and esophageal cancer risk. Furthermore, our results may be influenced by measurement errors of the dietary questionnaires that may have attenuated our findings. However, dietary questionnaires were country specific and previously validated for some flavonoid-rich foods, such as fruits, vegetables, tea, and wine (22, 23) . In addition dietary intake of flavonoids
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Am J Epidemiol. 2013;178(4):570-581 may have been underestimated, since the flavonoid database was not complete and the herb/plant supplement intakes were omitted in this analysis (up to 5% in Denmark, the country with the highest consumption in EPIC) (48) ; however, for this study an extensive common database was used (25) (26) (27) (28) . Moreover, in the present study, we do not take into account that individual flavonoids have different bioavailabilities (from low to moderate) and that they may also have different biological effects (43, 44) . Next, some individuals may have modified their diet during the early pre-diagnostic period of the disease, but sensitivity analyses excluding incident cases diagnosed in the first 2 years of follow-up did not alter the risk estimates, although as expected the confidence intervals became wider. No information was obtained on Barrett's esophagus in the EPIC study, but 95% of EAC arises in individuals without a prior diagnosis of Barrett's esophagus (5) . Further, a diet high in flavonoids reflects in our study a healthier lifestyle, such as being physically active and not smoking. Though we have adjusted our models for several important indicators of healthy lifestyle, the presence of possible residual confounding cannot be excluded. Finally, we realize that our study is prone to the well-known drawback of multiple comparisons.
In conclusion, no statistically significant associations were observed between dietary intake of flavonoids and overall esophageal cancer risk, nor for risk of morphological subtypes (EAC and ESCC). Nevertheless, there was a significant inverse association between dietary intake of total Abbreviations: CI, confidence interval; HR, hazard ratio. a Minimally adjusted model stratified by center, age (1 year), and sex and adjusted for energy intake (kcal/day). b Additionally adjusted for body mass index, smoking intensity, educational level, physical activity, alcohol (g/day), and red and processed meat intake (g/day).
c Additionally adjusted for fiber (g/day), vitamin C (mg/day), and carotenoids (µg/day). d Tests for linear trend were performed by assigning the median of each quartile/tertile as scores.
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Am J Epidemiol. 2013;178(4):570-581 Abbreviations: CI, confidence interval; HR, hazard ratio. a Hazard ratio for the continuous variable (log 2 ). Model is stratified by center, age, and sex and adjusted for body mass index, educational level, physical activity, energy (kcal/day), alcohol (g/day), and red and processed meat (g/day).
b Additionally adjusted for fiber (g/day), vitamin C (mg/day), and carotenoids (µg/day). c Heterogeneity among tobacco status categories is assessed by using the likelihood ratio test on the models with and without the interaction terms.
